- Home
- FORM vs VCYT Comparison
FORM vs VCYT Comparison
Compare FORM & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORM
- VCYT
- Stock Information
- Founded
- FORM 1993
- VCYT 2006
- Country
- FORM United States
- VCYT United States
- Employees
- FORM N/A
- VCYT N/A
- Industry
- FORM Semiconductors
- VCYT Medical Specialities
- Sector
- FORM Technology
- VCYT Health Care
- Exchange
- FORM Nasdaq
- VCYT Nasdaq
- Market Cap
- FORM 3.0B
- VCYT 2.9B
- IPO Year
- FORM N/A
- VCYT 2013
- Fundamental
- Price
- FORM $48.84
- VCYT $38.56
- Analyst Decision
- FORM Buy
- VCYT Buy
- Analyst Count
- FORM 8
- VCYT 9
- Target Price
- FORM $48.57
- VCYT $43.56
- AVG Volume (30 Days)
- FORM 1.4M
- VCYT 1.0M
- Earning Date
- FORM 10-29-2025
- VCYT 11-04-2025
- Dividend Yield
- FORM N/A
- VCYT N/A
- EPS Growth
- FORM N/A
- VCYT N/A
- EPS
- FORM 0.53
- VCYT 0.38
- Revenue
- FORM $759,313,000.00
- VCYT $495,141,000.00
- Revenue This Year
- FORM $3.95
- VCYT $14.52
- Revenue Next Year
- FORM $10.24
- VCYT $9.90
- P/E Ratio
- FORM $92.08
- VCYT $101.89
- Revenue Growth
- FORM 2.29
- VCYT 16.41
- 52 Week Low
- FORM $22.58
- VCYT $22.61
- 52 Week High
- FORM $61.10
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- FORM 52.02
- VCYT 51.60
- Support Level
- FORM $48.00
- VCYT $38.28
- Resistance Level
- FORM $53.67
- VCYT $39.83
- Average True Range (ATR)
- FORM 2.98
- VCYT 2.02
- MACD
- FORM -0.94
- VCYT -0.26
- Stochastic Oscillator
- FORM 7.72
- VCYT 30.97
About FORM FormFactor Inc. FormFactor Inc.
FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.